CATX Annual Operating Expenses
$40.94 M
+$32.53 M+386.93%
01 December 2023
Summary:
As of January 21, 2025, CATX annual total operating expenses is $40.94 million, with the most recent change of +$32.53 million (+386.93%) on December 1, 2023. During the last 3 years, it has risen by +$32.38 million (+378.39%). CATX annual operating expenses is now at all-time high.CATX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX Quarterly Operating Expenses
$18.63 M
+$4.37 M+30.65%
01 September 2024
Summary:
As of January 21, 2025, CATX quarterly total operating expenses is $18.63 million, with the most recent change of +$4.37 million (+30.65%) on September 1, 2024. Over the past year, it has increased by +$8.88 million (+91.12%). CATX quarterly operating expenses is now at all-time high.CATX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CATX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +386.9% | +91.1% |
| 3 y3 years | +378.4% | +91.3% |
| 5 y5 years | +391.8% | +91.3% |
CATX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +386.9% | at high | +561.5% |
| 5 y | 5-year | at high | +391.8% | at high | +850.7% |
| alltime | all time | at high | +114.9% | at high | >+9999.0% |
Perspective Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.63 M(+30.6%) |
| June 2024 | - | $14.26 M(+9.7%) |
| Mar 2024 | - | $13.01 M(+11.2%) |
| Dec 2023 | $40.94 M(+386.9%) | $11.70 M(+20.0%) |
| Sept 2023 | - | $9.75 M(-0.0%) |
| June 2023 | - | $9.75 M(+0.2%) |
| Mar 2023 | - | $9.74 M(+110.7%) |
| Dec 2022 | $8.41 M(-30.0%) | - |
| Sept 2022 | - | $4.62 M(+52.4%) |
| June 2022 | - | $3.03 M(+7.6%) |
| June 2022 | $12.01 M(+40.3%) | - |
| Mar 2022 | - | $2.82 M(-1.3%) |
| Dec 2021 | - | $2.85 M(-13.6%) |
| Sept 2021 | - | $3.30 M(+35.4%) |
| June 2021 | $8.56 M(-0.5%) | - |
| June 2021 | - | $2.44 M(+14.7%) |
| Mar 2021 | - | $2.13 M(+4.6%) |
| Dec 2020 | - | $2.03 M(+3.7%) |
| Sept 2020 | - | $1.96 M(-13.3%) |
| June 2020 | $8.60 M(+3.3%) | $2.26 M(+0.3%) |
| Mar 2020 | - | $2.25 M(+11.9%) |
| Dec 2019 | - | $2.01 M(-2.8%) |
| Sept 2019 | - | $2.07 M(+2.4%) |
| June 2019 | $8.32 M(-2.9%) | $2.02 M(-1.0%) |
| Mar 2019 | - | $2.04 M(-7.8%) |
| Dec 2018 | - | $2.22 M(+8.6%) |
| Sept 2018 | - | $2.04 M(-27.3%) |
| June 2018 | $8.57 M(+19.9%) | $2.81 M(+44.1%) |
| Mar 2018 | - | $1.95 M(-2.6%) |
| Dec 2017 | - | $2.00 M(+10.0%) |
| Sept 2017 | - | $1.82 M(-23.1%) |
| June 2017 | $7.15 M(+37.2%) | $2.36 M(+40.5%) |
| Mar 2017 | - | $1.68 M(+13.8%) |
| Dec 2016 | - | $1.48 M(-8.9%) |
| Sept 2016 | - | $1.62 M(+34.6%) |
| June 2016 | $5.21 M(+15.7%) | $1.21 M(-13.5%) |
| Mar 2016 | - | $1.39 M(-3.0%) |
| Dec 2015 | - | $1.44 M(+22.4%) |
| Sept 2015 | - | $1.17 M(-10.3%) |
| June 2015 | $4.50 M(+2.6%) | $1.31 M(+18.3%) |
| Mar 2015 | - | $1.11 M(+12.6%) |
| Dec 2014 | - | $982.30 K(-11.2%) |
| Sept 2014 | - | $1.11 M(-8.0%) |
| June 2014 | $4.39 M(+4.1%) | $1.20 M(+20.2%) |
| Mar 2014 | - | $1.00 M(-0.9%) |
| Dec 2013 | - | $1.01 M(-12.7%) |
| Sept 2013 | - | $1.16 M(+2.2%) |
| June 2013 | $4.22 M(-1.9%) | $1.13 M(+10.0%) |
| Mar 2013 | - | $1.03 M(+2.3%) |
| Dec 2012 | - | $1.01 M(-8.8%) |
| Sept 2012 | - | $1.10 M(-6.1%) |
| June 2012 | $4.30 M(+4.4%) | $1.17 M(+21.4%) |
| Mar 2012 | - | $967.10 K(-2.4%) |
| Dec 2011 | - | $990.90 K(-15.2%) |
| Sept 2011 | - | $1.17 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2011 | $4.12 M(-13.0%) | $1.22 M(+16.4%) |
| Mar 2011 | - | $1.05 M(+37.8%) |
| Dec 2010 | - | $762.60 K(-29.7%) |
| Sept 2010 | - | $1.08 M(-14.3%) |
| June 2010 | $4.73 M(-22.6%) | $1.26 M(+10.6%) |
| Mar 2010 | - | $1.14 M(-5.8%) |
| Dec 2009 | - | $1.21 M(+8.9%) |
| Sept 2009 | - | $1.11 M(-7.5%) |
| June 2009 | $6.12 M(-29.3%) | $1.20 M(-19.6%) |
| Mar 2009 | - | $1.50 M(-11.1%) |
| Dec 2008 | - | $1.69 M(-2.5%) |
| Sept 2008 | - | $1.73 M(-3.0%) |
| June 2008 | $8.65 M(-10.3%) | $1.78 M(-18.7%) |
| Mar 2008 | - | $2.19 M(-10.8%) |
| Dec 2007 | - | $2.46 M(+10.8%) |
| Sept 2007 | - | $2.22 M(-21.9%) |
| June 2007 | $9.65 M(+79.5%) | $2.84 M(+27.7%) |
| Mar 2007 | - | $2.22 M(+15.4%) |
| Dec 2006 | - | $1.93 M(-27.3%) |
| Sept 2006 | - | $2.65 M(+46.6%) |
| June 2006 | $5.37 M(-102.0%) | $1.81 M(+57.3%) |
| Mar 2006 | - | $1.15 M(+3.4%) |
| Dec 2005 | - | $1.11 M(-14.5%) |
| Sept 2005 | - | $1.30 M(+331.1%) |
| June 2005 | -$274.37 M(<-9900.0%) | - |
| Mar 2005 | - | $302.00 K(+8288.9%) |
| Dec 2004 | - | $3600.00(-14.3%) |
| Sept 2004 | $9100.00(-52.1%) | $4200.00(-44.0%) |
| June 2004 | - | $7500.00(+368.8%) |
| Mar 2004 | - | $1600.00(-85.2%) |
| Dec 2003 | - | $10.80 K(+54.3%) |
| Sept 2003 | $19.00 K(+150.0%) | $7000.00(+288.9%) |
| June 2003 | - | $1800.00(-33.3%) |
| Mar 2003 | - | $2700.00(-64.5%) |
| Dec 2002 | - | $7600.00(-2633.3%) |
| Sept 2002 | $7600.00(-51.3%) | -$300.00(-120.0%) |
| June 2002 | - | $1500.00(-69.4%) |
| Mar 2002 | - | $4900.00(+226.7%) |
| Dec 2001 | - | $1500.00(-11.8%) |
| Sept 2001 | $15.60 K(+10.6%) | $1700.00(-84.4%) |
| June 2001 | - | $10.90 K(+990.0%) |
| Mar 2001 | - | $1000.00(-52.4%) |
| Dec 2000 | - | $2100.00(-85.1%) |
| Sept 2000 | $14.10 K(-9.0%) | $14.10 K(>+9900.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) |
| Dec 1999 | - | $0.00(-100.0%) |
| Sept 1999 | $15.50 K(-93.0%) | $12.60 K(+1700.0%) |
| June 1999 | - | $700.00(+40.0%) |
| Mar 1999 | - | $500.00(-81.5%) |
| Dec 1998 | - | $2700.00 |
| Sept 1998 | $222.80 K(-25.7%) | - |
| Sept 1997 | $299.80 K(-89.7%) | - |
| Sept 1996 | $2.91 M(+76.1%) | - |
| Sept 1995 | $1.65 M(+7.4%) | - |
| Sept 1994 | $1.54 M | - |
FAQ
- What is Perspective Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Perspective Therapeutics?
- What is Perspective Therapeutics annual operating expenses year-on-year change?
- What is Perspective Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly operating expenses year-on-year change?
What is Perspective Therapeutics annual total operating expenses?
The current annual operating expenses of CATX is $40.94 M
What is the all time high annual operating expenses for Perspective Therapeutics?
Perspective Therapeutics all-time high annual total operating expenses is $40.94 M
What is Perspective Therapeutics annual operating expenses year-on-year change?
Over the past year, CATX annual total operating expenses has changed by +$32.53 M (+386.93%)
What is Perspective Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CATX is $18.63 M
What is the all time high quarterly operating expenses for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly total operating expenses is $18.63 M
What is Perspective Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CATX quarterly total operating expenses has changed by +$8.88 M (+91.12%)